Stay updated on Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.

Latest updates to the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page
- Check7 days agoChange DetectedThe date on the webpage has been updated from February 4, 2025, to March 4, 2025.SummaryDifference0.3%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact for assistance. Additionally, a date has been updated from January 16, 2025, to February 4, 2025.SummaryDifference6%
- Check43 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check57 days agoChange DetectedThe website has been updated to version 2.14.1 on January 16, 2025, following the removal of version 2.14.0 on January 3, 2025.SummaryDifference0.6%
- Check64 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
Stay in the know with updates to Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.